Intervention not reported
Guideline‐consistent prescribing of medication · General practitioners/family doctors involved in the management of patients with other musculoskeletal conditions
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Medication2 · General practitioners/family doctors involved in the management of patients with osteoporosis
Primary care physician alerting system showed no clear difference in medication2 compared with primary care physician alerting system and a patient‐directed… (moderate certainty).
1 finding from 1 review
Intervention not reported
Health professional (GP) behaviour‐related outcomes Bone Mineral Density (BMD) testing Osteoporosis medication (appropriate prescribing) · General practitioners/family doctors involved in the management of patients with osteoporosis
1 finding from 1 review
Intervention not reported
Medication‐related problems · older people (aged 65 years or older) living in care homes
1 finding from 1 review
Intervention not reported
Medication appropriateness · older people (aged 65 years or older) living in care homes
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication adherence ATCS Plus versus usual care · cancer patients
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication adherence or use ATCS Plus versus usual care, 6‐12 months · patients with diabetes mellitus
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication use Multimodal/complexk, ATCS Plus versus usual care or enhanced usual care (plus information) · patients with hypertension
1 finding from 1 review
Intervention not reported
Behavioural outcome: medication use Multimodal/complex, ATCS Plus versus control (inactive IVR or self‐help booklet) · patients with tobacco dependence
1 finding from 1 review
Intervention not reported
Reduced asthma medication usage · People with asthma (mostly mild or moderate)
The intervention may leads to higher reduced asthma medication usage (low certainty).
1 finding from 1 review
Adverse effects: Extrapyramidal effects ‐ concomitant anticholinergic medication ‐ short term (up to 12 weeks) Participants requiring concomitant anticholinergic medication · patients with schizophrenia
It is very uncertain whether FLUPHENAZINE (ORAL) changes adverse effects: Extrapyramidal effects ‐ concomitant… compared with AMISULPRIDE (very low certainty).
1 finding from 1 review
Intervention not reported
Freedom from AF/AFL/AT off antiarrhythmic medications > 3 months · individuals with atrial fibrillation who are undergoing cardiac surgery
The intervention probably leads to higher freedom from AF/AFL/AT off antiarrhythmic medications > 3 months (moderate certainty).
1 finding from 1 review
Adherence · adults and adolescents with asthma
1 finding from 1 review
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Use of rescue medication · adults with episodic tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Median (mean) time to use of rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Number of women requiring rescue medication · adults with moderate or severe acute postoperative pain
1 finding from 1 review
Dose/intensity and frequency of pain relief needed (analgesic/rescue medication use) · Adolescents/teenagers undergoing orthodontic treatment
1 finding from 1 review
Symptomatic/analgesic medication use for acute headache attacks · patients for whom migraine preventive interventions are indicated
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found